News | Wearables
For people at heightened risk for atrial fibrillation (AFib), a common heart rhythm disorder that also carries a high risk of stroke, wearing a self-adhering chest patch that records heart patterns may better detect the condition and facilitate more timely treatment than relying on usual care, according to one-year data presented at the American College of Cardiology’s 67th Annual Scientific Session, March 10-12 in Orlando, Fla.
March 19, 2018
Technology | Artificial Intelligence
March 19, 2018 — Philips recently announced the launch of HealthSuite Insights, including the Insights Marketplace, to ...
March 19, 2018
Videos | Cath Lab
A discussion with Hitinder Gurm, M.D., MBBS, FACC, professor, internal medicine, and associate chief clinical officer ...
March 15, 2018Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Videos | Heart Valve Technology
Insights from the STS/ACC TVT Transcatheter Valve Registry, presented at the American College of Cardiology (ACC) 2018 ...
March 15, 2018
March 15, 2018 – Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who works in ...
March 15, 2018
Videos | FFR Technologies
An economic analysis of the DEFINE-FLAIR study comparing FFR vs. iFR, found a cost savings of nearly $900. The late ...
March 15, 2018Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News | ACC
March 15, 2018 — For people living with both Type 2 diabetes and heart failure, taking an aspirin each day appears to ...
March 15, 2018
News | ACC
March 15, 2018 – A newly-designed wristband and corresponding app that works with a smartwatch can accurately display ...
March 15, 2018
News | ACC
March 15, 2018 — For people with heart failure, getting a seasonal influenza (flu) vaccine in a given year was ...
March 15, 2018Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | ACC
March 15, 2018 — Women with normal blood pressure during pregnancy and who breastfed their babies for at least six ...
March 15, 2018
News | ACC
March 15, 2018 — Women diagnosed with preeclampsia during pregnancy were significantly more likely to develop high blood ...
March 15, 2018
March 14, 2018 — A late-breaking analysis of the landmark COMPASS study presented at the American College of Cardiology ...
March 14, 2018Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Videos | Sudden Cardiac Arrest
The Zoll LifeVest is a temporary, wearable defibrillator designed as a safety net for patients, especially those being ...
March 14, 2018
News | Cardio-oncology
After six months of follow-up, women newly diagnosed with breast cancer who were given the beta blocker carvedilol to prevent heart issues while undergoing chemotherapy showed no difference in declines in heart function compared with those taking a placebo. Patients who took carvedilol, however, were significantly less likely to have an elevated marker in the blood that signals injury to the heart, according to a study being presented at the American College of Cardiology’s (ACC) 67th Annual Scientific Session, March 10-12 in Orlando, Fla.
March 14, 2018
News | Cardio-oncology
March 14, 2018 — Breast cancer patients who started taking one of two well-known heart medications at the same time they ...
March 14, 2018© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now